These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 15115562

  • 1. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M, Moll JJ, Krajewski W, Jarosik P.
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [Abstract] [Full Text] [Related]

  • 2. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

  • 3. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 4. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [Abstract] [Full Text] [Related]

  • 5. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [Abstract] [Full Text] [Related]

  • 6. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT, Juul JJ, G Rinka JR, Baumann Kreuziger LM, Pagel PS, Tawil JN.
    Ann Card Anaesth; 2019 Apr; 22(4):388-393. PubMed ID: 31621674
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
    Tatoulis J, Theodore S, Meswani M, Wynne R, Hon-Yap C, Powar N.
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
    [Abstract] [Full Text] [Related]

  • 12. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
    Raivio P, Suojaranta-Ylinen R, Kuitunen AH.
    Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
    [Abstract] [Full Text] [Related]

  • 13. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
    Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.
    J Intensive Care Med; 2004 Jul; 19(5):270-3. PubMed ID: 15358945
    [Abstract] [Full Text] [Related]

  • 14. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y, Zhao W, Luo Q, Wu X, Ding J, Yan F.
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [Abstract] [Full Text] [Related]

  • 15. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
    Ekert H, Brizard C, Eyers R, Cochrane A, Henning R.
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):389-95. PubMed ID: 16788315
    [Abstract] [Full Text] [Related]

  • 16. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
    Downey L, Brown ML, Faraoni D, Zurakowski D, DiNardo JA.
    Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass.
    Naik VN, Mazer CD, Latter DA, Teitel JM, Hare GM.
    Can J Anaesth; 2003 May; 50(6):599-602. PubMed ID: 12826554
    [Abstract] [Full Text] [Related]

  • 18. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC, He Y, Taylor MB.
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [Abstract] [Full Text] [Related]

  • 19. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
    Tritapepe L, De Santis V, Vitale D, Nencini C, Pellegrini F, Landoni G, Toscano F, Miraldi F, Pietropaoli P.
    Crit Care Med; 2007 Jul; 35(7):1685-90. PubMed ID: 17522585
    [Abstract] [Full Text] [Related]

  • 20. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV, Renwick WE, Hogan C, Haeusler M, Tuckfield A, Tatoulis J.
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.